• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界卫生组织综合证据到决策框架的制定:健康决策制定决策标准系统评价概述

Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making.

作者信息

Stratil J M, Baltussen R, Scheel I, Nacken A, Rehfuess E A

机构信息

1Institute for Medical Information Processing, Biometry and Epidemiology, Pettenkofer School of Public Health, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.

2Department for Health Evidence, Radboud University Medical Center, P.O.Box 9101, 6500 HB Nijmegen, The Netherlands.

出版信息

Cost Eff Resour Alloc. 2020 Feb 11;18:8. doi: 10.1186/s12962-020-0203-6. eCollection 2020.

DOI:10.1186/s12962-020-0203-6
PMID:32071560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7014604/
Abstract

BACKGROUND

Decision-making in public health and health policy is complex and requires careful deliberation of many and sometimes conflicting normative and technical criteria. Several approaches and tools, such as multi-criteria decision analysis, health technology assessments and evidence-to-decision (EtD) frameworks, have been proposed to guide decision-makers in selecting the criteria most relevant and appropriate for a transparent decision-making process. This study forms part of the development of the WHO-INTEGRATE EtD framework, a framework rooted in global health norms and values as reflected in key documents of the World Health Organization and the United Nations system. The objective of this study was to provide a comprehensive overview of criteria used in or proposed for real-world decision-making processes, including guideline development, health technology assessment, resource allocation and others.

METHODS

We conducted an overview of systematic reviews through a combination of systematic literature searches and extensive reference searches. Systematic reviews reporting criteria used for real-world health decision-making by governmental or non-governmental organization on a supranational, national, or programme level were included and their quality assessed through a bespoke critical appraisal tool. The criteria reported in the reviews were extracted, de-duplicated and sorted into first-level (i.e. ), second-level (i.e. -) and third-level (i.e. ) categories. First-level categories were developed a priori using a normative approach; second- and third-level categories were developed inductively.

RESULTS

We included 36 systematic reviews providing criteria, of which one met all and another eleven met at least five of the items of our critical appraisal tool. The criteria were subsumed into 8 45 - and 200 . The first-level of the category system comprised the following seven substantive criteria: "Health-related balance of benefits and harms"; "Human and individual rights"; "Acceptability considerations"; "Societal considerations"; "Considerations of equity, equality and fairness"; "Cost and financial considerations"; and "Feasibility and health system considerations". In addition, we identified an eight criterion "Evidence".

CONCLUSION

This overview of systematic reviews provides a comprehensive overview of criteria used or suggested for real-world health decision-making. It also discusses key challenges in the selection of the most appropriate criteria and in seeking to implement a fair decision-making process.

摘要

背景

公共卫生和卫生政策中的决策十分复杂,需要仔细权衡诸多有时相互冲突的规范性和技术性标准。已提出了多种方法和工具,如多标准决策分析、卫生技术评估以及证据到决策(EtD)框架,以指导决策者选择与透明决策过程最相关且合适的标准。本研究是世界卫生组织综合EtD框架开发工作的一部分,该框架基于世界卫生组织和联合国系统关键文件中所反映的全球卫生规范和价值观。本研究的目的是全面概述在实际决策过程中使用或提出的标准,包括指南制定、卫生技术评估、资源分配等。

方法

我们通过系统文献检索和广泛的参考文献检索相结合的方式,对系统评价进行了概述。纳入了报告政府或非政府组织在超国家、国家或项目层面用于实际卫生决策的标准的系统评价,并通过定制的批判性评价工具对其质量进行评估。从评价中报告的标准进行提取、去重,并分类为一级(即 )、二级(即 -)和三级(即 )类别。一级类别采用规范性方法预先确定;二级和三级类别通过归纳法确定。

结果

我们纳入了36项提供标准的系统评价,其中1项符合所有标准,另有11项至少符合我们批判性评价工具的5项标准。这些标准被归纳为8个 、45个 和200个 。类别系统的一级包括以下七个实质性标准:“健康相关的利弊平衡”;“人权与个人权利”;“可接受性考量”;“社会考量”;“公平、平等和公正考量”;“成本和财务考量”;以及“可行性和卫生系统考量”。此外,我们确定了第八个标准“证据”。

结论

本系统评价概述提供了实际卫生决策中使用或建议使用的标准的全面概述。它还讨论了选择最合适标准以及寻求实施公平决策过程中的关键挑战。

相似文献

1
Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making.世界卫生组织综合证据到决策框架的制定:健康决策制定决策标准系统评价概述
Cost Eff Resour Alloc. 2020 Feb 11;18:8. doi: 10.1186/s12962-020-0203-6. eCollection 2020.
2
The WHO-INTEGRATE evidence to decision framework version 1.0: integrating WHO norms and values and a complexity perspective.世界卫生组织-整合证据到决策框架第1.0版:整合世界卫生组织的规范和价值观以及复杂性视角。
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000844. doi: 10.1136/bmjgh-2018-000844. eCollection 2019.
3
Advancing the WHO-INTEGRATE Framework as a Tool for Evidence-Informed, Deliberative Decision-Making Processes: Exploring the Views of Developers and Users of WHO Guidelines.推进世卫组织综合框架作为循证决策过程的工具:探索世卫组织指南制定者和使用者的观点。
Int J Health Policy Manag. 2022 May 1;11(5):629-641. doi: 10.34172/ijhpm.2020.193.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Risk management frameworks for human health and environmental risks.人类健康与环境风险的风险管理框架。
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.
6
WICID framework version 1.0: criteria and considerations to guide evidence-informed decision-making on non-pharmacological interventions targeting COVID-19.WICID 框架 1.0 版:指导针对 COVID-19 的非药物干预措施进行循证决策的标准和考虑因素。
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-003699.
7
Applying the WHO-INTEGRATE evidence-to-decision framework in the development of WHO guidelines on parenting interventions: step-by-step process and lessons learnt.运用世卫组织整合证据决策框架制定世卫组织育儿干预措施指南:逐步过程和经验教训。
Health Res Policy Syst. 2024 Jul 5;22(1):79. doi: 10.1186/s12961-024-01165-z.
8
Evidence-to-decision frameworks: a review and analysis to inform decision-making for environmental health interventions.证据决策框架:为环境健康干预措施的决策提供信息的综述与分析。
Environ Health. 2021 Dec 8;20(1):124. doi: 10.1186/s12940-021-00794-z.
9
Universal Health Coverage and Essential Packages of Care全民健康覆盖与基本医疗服务包
10
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.

引用本文的文献

1
Frameworks to support evidence-informed decision-making in public health and infectious disease prevention and control: a scoping review.支持公共卫生及传染病预防与控制中循证决策的框架:一项范围综述
Euro Surveill. 2025 May;30(19). doi: 10.2807/1560-7917.ES.2025.30.19.2400185.
2
Development of an overarching framework for anticipating and assessing adverse and other unintended consequences of public health interventions (CONSEQUENT): a best-fit framework synthesis.制定一个用于预测和评估公共卫生干预措施的不良及其他意外后果的总体框架(CONSEQUENT):最佳适配框架综合法
BMJ Public Health. 2024 Feb 20;2(1):e000209. doi: 10.1136/bmjph-2023-000209. eCollection 2024 Jun.
3
Key attributes of health and environmental risk decision-making: A scoping review.健康与环境风险决策的关键属性:一项范围综述。
Risk Anal. 2025 Jul;45(7):1926-1939. doi: 10.1111/risa.17715. Epub 2025 Feb 2.
4
An integrated framework to guide evidence-informed public health policymaking.一个指导基于证据的公共卫生政策制定的综合框架。
J Public Health Policy. 2025 Mar;46(1):193-210. doi: 10.1057/s41271-024-00535-9. Epub 2025 Jan 11.
5
Developing and Evaluating Digital Public Health Interventions Using the Digital Public Health Framework DigiPHrame: A Framework Development Study.利用数字公共卫生框架 DigiPHrame 开发和评估数字公共卫生干预措施:框架开发研究。
J Med Internet Res. 2024 Sep 12;26:e54269. doi: 10.2196/54269.
6
Applying the WHO-INTEGRATE evidence-to-decision framework in the development of WHO guidelines on parenting interventions: step-by-step process and lessons learnt.运用世卫组织整合证据决策框架制定世卫组织育儿干预措施指南:逐步过程和经验教训。
Health Res Policy Syst. 2024 Jul 5;22(1):79. doi: 10.1186/s12961-024-01165-z.
7
Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance.加强卫生技术评估中临床试验证据的真实世界证据:对七个国家真实世界证据要求的批判性综述及提高接受度的建议
J Mark Access Health Policy. 2024 May 20;12(2):105-117. doi: 10.3390/jmahp12020009. eCollection 2024 Jun.
8
Exploring evidence use and capacity for health services management and planning in Swiss health administrations: A mixed-method interview study.探索瑞士卫生行政部门在卫生服务管理和规划方面的证据使用和能力:一项混合方法访谈研究。
PLoS One. 2024 May 8;19(5):e0302864. doi: 10.1371/journal.pone.0302864. eCollection 2024.
9
Institutional Priority-Setting for Novel Drugs and Therapeutics: A Qualitative Systematic Review.新型药物和疗法的机构优先排序:定性系统评价。
Int J Health Policy Manag. 2024;13:7494. doi: 10.34172/ijhpm.2024.7494. Epub 2024 Feb 10.
10
Priority-setting for hospital funding of high-cost innovative drugs and therapeutics: A qualitative institutional case study.优先考虑医院为高成本创新药物和疗法提供资金:一项定性的机构案例研究。
PLoS One. 2024 Mar 18;19(3):e0300519. doi: 10.1371/journal.pone.0300519. eCollection 2024.

本文引用的文献

1
The WHO-INTEGRATE evidence to decision framework version 1.0: integrating WHO norms and values and a complexity perspective.世界卫生组织-整合证据到决策框架第1.0版:整合世界卫生组织的规范和价值观以及复杂性视角。
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000844. doi: 10.1136/bmjgh-2018-000844. eCollection 2019.
2
Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries.成本效益分析中公平性考量因素:低收入和中等收入国家轮状病毒疫苗的系统评价
Cost Eff Resour Alloc. 2018 May 18;16:18. doi: 10.1186/s12962-018-0102-2. eCollection 2018.
3
Value judgment of health interventions from different perspectives: arguments and criteria.从不同视角对健康干预措施的价值判断:论据与标准
Cost Eff Resour Alloc. 2018 Apr 17;16:16. doi: 10.1186/s12962-018-0099-6. eCollection 2018.
4
The Use of MCDA in HTA: Great Potential, but More Effort Needed.多准则决策分析在卫生技术评估中的应用:潜力巨大,但仍需努力。
Value Health. 2018 Apr;21(4):394-397. doi: 10.1016/j.jval.2017.10.001. Epub 2017 Nov 22.
5
Evaluating healthcare priority setting at the meso level: A thematic review of empirical literature.评估中观层面的医疗保健优先事项设定:实证文献的主题综述
Wellcome Open Res. 2018 Jan 8;3:2. doi: 10.12688/wellcomeopenres.13393.2. eCollection 2018.
6
Scoping literature review on the basic health benefit package and its determinant criteria.基本卫生福利包及其决定标准的范围文献综述。
Global Health. 2018 Mar 2;14(1):26. doi: 10.1186/s12992-018-0345-x.
7
Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review.将社会公正问题纳入医疗保健和公共卫生的经济评估中:系统评价。
Soc Sci Med. 2018 Feb;198:27-35. doi: 10.1016/j.socscimed.2017.12.012. Epub 2017 Dec 14.
8
Using multi-criteria decision analysis to appraise orphan drugs: a systematic review.运用多标准决策分析评估罕见病药物:一项系统综述
Expert Rev Pharmacoecon Outcomes Res. 2018 Apr;18(2):135-146. doi: 10.1080/14737167.2018.1414603. Epub 2017 Dec 20.
9
Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review.决策者在健康技术评估中进行优先排序的揭示偏好和陈述偏好:系统评价。
Pharmacoeconomics. 2018 Mar;36(3):323-340. doi: 10.1007/s40273-017-0586-1.
10
The evolution of public health ethics frameworks: systematic review of moral values and norms in public health policy.公共卫生伦理框架的演变:对公共卫生政策中道德价值观和规范的系统评价
Med Health Care Philos. 2018 Sep;21(3):387-402. doi: 10.1007/s11019-017-9813-y.